Hyperphosphatemia Treatment Market Size, Share & Growth Analysis, By Drug Class (Sevelamer, Calcium-based Phosphate Binders, Lanthanum Carbonate, Iron-based Phosphate Binders, Others, and Non-Phosphate Binders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 8.2% from 2023-2030

Unit

Value (USD billion)

Segmentation

By Drug Class

• Sevelamer
• Calcium-based Phosphate Binders
• Lanthanum Carbonate
• Iron-based Phosphate Binders
• Others
• Non-Phosphate Binders

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America (By Drug Class, By Distribution Channel, and By Country)
  • U.S.
  • Canada
• Europe (By Drug Class, By Distribution Channel, and By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Drug Class, By Distribution Channel, and By Country/Sub-region)
  • Japan
  • China
  • Australia
  • India
  • South East Asia
  • Rest of Asia Pacific
• Latin America (By Drug Class, By Distribution Channel, and By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Drug Class, By Distribution Channel, and By Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa